Ronald Todd Plott
CIK: 0001768337
Transaction Breakdown
Open Market Buys (P)1 (50.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PHIO
Phio Pharmaceuticals Corp.
Director
Discretionary Trading P&L
Holdings
About Plott Ronald Todd
Plott Ronald Todd (SEC CIK 0001768337) files insider reports with the SEC as Director of Phio Pharmaceuticals Corp. (PHIO).
Signal8 holds 3 ownership filings by Plott Ronald Todd (1 Form 3, 2 Form 4), filed between Jul 30, 2026 and Sep 29, 2026. Those filings report 2 transactions, from Aug 19, 2026 to Sep 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Plott Ronald Todd's filings is in KING OF PRUSSIA, PA.
Recent filings by Plott Ronald Todd
Other insiders filing for Phio Pharmaceuticals Corp. (PHIO)
- Carson Lisa Cabott, Chief Financial Officer
- Bitterman Robert J, Chairman, Pres. & CEO
- BRADFORD PATRICIA A, Director
- Lockshin Curtis, Director
- Freeman Jonathan E, Director
- Deming David H, Director